Satellos Bioscience (STU:0IT) Forward Dividend Yield %: 0.00% (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:0IT Satellos Bioscience Inc STU:0IT
35 GF Score
Price €8.00
! 1 Warning Sign
View Full Analysis

What is Satellos Bioscience Forward Dividend Yield %?

Satellos Bioscience STU:0IT -1.84% 35 Forward Dividend Yield % is 0.00% as of Jul. 14, 2026. GuruFocus rates STU:0IT with a GF Score™ of 35/100. The stock has 1 warning sign investors should review. Among 148 Biotechnology companies, Satellos Bioscience ranks worse than 675675% on this metric.

As of today (2026-07-14), the Forward Annual Dividend Yield of Satellos Bioscience is 0.00%.

As of today (2026-07-14), the Trailing Annual Dividend Yield of Satellos Bioscience is 0.00%.

STU:0IT's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.26
* Ranked among companies with meaningful Forward Dividend Yield % only.

Satellos Bioscience's Dividends per Share for the three months ended in Mar. 2026 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Satellos Bioscience  (STU:0IT) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Satellos Bioscience Forward Dividend Yield % Related Terms

STU:0IT vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison

For the Biotechnology subindustry, Satellos Bioscience's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Satellos Bioscience Forward Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Satellos Bioscience's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Satellos Bioscience's Forward Dividend Yield % falls into.


STU:0IT
35GF Score
Satellos Bioscience Inc STU:0IT
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Satellos Bioscience Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Satellos Bioscience (STU:0IT) has a Forward Dividend Yield % of 0.00% as of Jul. 14, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Satellos Bioscience and its competitors. According to the industry distribution chart, Satellos Bioscience ranks #999999 out of 148 companies in the Biotechnology industry.
Is Satellos Bioscience's Forward Dividend Yield % too high?
Satellos Bioscience's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Satellos Bioscience ranks #999999 out of 148 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Satellos Bioscience has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Satellos Bioscience's Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Satellos Bioscience ranks #999999 out of 148 companies for Forward Dividend Yield %. This places Satellos Bioscience in the lower half of its industry. The industry median Forward Dividend Yield % is 1.26. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.26, based on 148 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Satellos Bioscience and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Satellos Bioscience's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Satellos Bioscience stock overvalued right now?
Satellos Bioscience (STU:0IT) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Satellos Bioscience's overall GF Score™ is 35/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Satellos Bioscience (STU:0IT), the current Forward Dividend Yield % is 0.00% as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Satellos Bioscience Business Description

Address 200 Bay Street, Suite 2800, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
35GF Score

Get the complete analysis for STU:0IT

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.00
Price